---
title: 'Deep learning for [<sup>18</sup>F]fluorodeoxyglucose-PET-CT classification
  in patients with lymphoma: a dual-centre retrospective analysis'
date: '2023-12-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38135556/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&fc=20220814223158&ff=20231223170619&v=2.18.0
source: (deep learning) AND ((leukemia) OR (lymphoma))
description: 'BACKGROUND: The rising global cancer burden has led to an increasing
  demand for imaging tests such as [^(18)F]fluorodeoxyglucose ([^(18)F]FDG)-PET-CT.
  To aid imaging specialists in dealing with high scan volumes, we aimed to train
  a deep learning artificial intelligence algorithm to classify [^(18)F]FDG-PET-CT
  scans of patients with lymphoma with or without hypermetabolic tumour ...'
disable_comments: true
---
BACKGROUND: The rising global cancer burden has led to an increasing demand for imaging tests such as [^(18)F]fluorodeoxyglucose ([^(18)F]FDG)-PET-CT. To aid imaging specialists in dealing with high scan volumes, we aimed to train a deep learning artificial intelligence algorithm to classify [^(18)F]FDG-PET-CT scans of patients with lymphoma with or without hypermetabolic tumour ...